Zemuron and Yaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zemuron (rocuronium bromide) and Yaz (drospirenone; ethinyl estradiol). Common drug interactions include pulmonary embolism among females.

The phase IV clinical study analyzes what interactions people have when they take Zemuron and Yaz. It is created by eHealthMe based on reports of 9 people who take the same drugs from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Yaz?

Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,514 Yaz users. Check the latest studies of Yaz.



On Oct, 20, 2025

9 people who take Zemuron and Yaz together, and have interactions are studied.

Zemuron and Yaz drug interactions.

What are the common drug interactions of Zemuron and Yaz, by gender? *:

female:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Abdominal pain
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Dyspnoea (difficult or laboured respiration)
  5. Emotional distress
  6. General physical health deterioration (weak health status)
  7. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Injury

male:

n/a

What are the common drug interactions of Zemuron and Yaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Injury
  3. Pain

20-29:

  1. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Emotional distress
  3. General physical health deterioration (weak health status)
  4. Injury
  5. Pain
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Abdominal pain
  9. Anxiety
  10. Cholecystitis chronic (long lasting infection of gallbladder)

40-49:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
  3. Dyspnoea (difficult or laboured respiration)
  4. Injury
  5. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  6. Pain
  7. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and Yaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zemuron and Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zemuron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide and drospirenone; ethinyl estradiol (the active ingredients of Zemuron and Yaz, respectively), and Zemuron and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: